CIBC Bancorp USA’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Sell
1,216,044
-2,309
-0.2% -$6.35K 0.01% 761
2026
Q1
$1.63M Buy
+1,218,353
New +$2.43M ﹤0.01% 943

Other funds holding TMCI

CIBC Bancorp USA's TMCI Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Treace Medical Concepts (TMCI) stake by 0.19% in Q2 2026, selling an estimated $6.35K and leaving 1,216,044 shares worth $4.84M. The position accounts for 0.01% of the portfolio, ranked #761.

CIBC Bancorp USA first reported a position in TMCI in Q1 2026 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • CIBC Bancorp USA held 1,216,044 shares of Treace Medical Concepts worth $4.84M as of Q2 2026.
  • CIBC Bancorp USA sold 2,309 Treace Medical Concepts shares in Q2 2026, an estimated $6.35K.
  • Treace Medical Concepts made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #761 holding.
  • CIBC Bancorp USA first reported a position in Treace Medical Concepts in Q1 2026 and has held it in 2 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.